Consensus Development Conference on Antipsychotic Drugs and Obesity and Diabetes
Response to consensus statement
- Michael T. Isaac, MD and
- Maria B. Isaac, MD, PHD
- Ladywell Unit, South London and Maudsley National Health Service Trust, University Hospital Lewisham, Lewisham High Street, London, U.K
- Address correspondence to Dr. Michael T. Isaac, University Hospital Lewisham, South London and Maudsley National Health Service Trust, The Ladywell Unit, London SE13 6LH, U.K. E-mail: misaac{at}stekel.demon.co.uk
We of course welcome the fact that the issue of obesity and diabetes in the management of psychosis is taken seriously by the disciplines represented in this conference (1). However, as clinical psychiatrists we are concerned that some of the matters raised may give an unintentionally misleading message.
We are far from sure, for example, that the evidence supports the view that there is so much disparity in the incidence of obesity and diabetes among first-generation antipsychotics (FGAs) and second-generation antipsychotics (SGAs). Furthermore, there is no evidence, for that matter, of disparity …
